Research Mission Statement

Perform frontier research and transform results into cutting edge products to support drug development

Bayer Technology Services is a subsidiary of the Bayer AG, one of the leading research companies worldwide, annually investing more than EUR 2.5 billion into research and development to utilize science for a better life. In addition to these large investments, BTS is actively participating in publicly funded research projects within the area of computational systems biology. We acknowledge the support and enjoy the partnerships with research institutions, which have developed within these frameworks. Overall, BTS has established fruitful partnerships with many academic institutions and industrial corporations providing a track record for future projects.

Our commitment to frontier research is documented by publications in international scientific journals, poster presentations and talks on conferences, and our software solutions for PBPK and systems biology research. Together with our services, this makes a real difference to support drug development.

Find out more about our

Quicksearch Quicksearch

April 23, 2009

New on-line services are now available!

» More

February 05, 2009

First milestone reached in research project on the predictive modeling of cancer therapies

» More

January 30, 2009

PK-Sim® Version 4.1 is now available!

» More

July 18, 2009

36th Annual Meeting and Exposition of the Controlled Release Society, Copenhagen, Denmark, July 18-22

» More

September 14, 2009

Bioinformatics Workshop at the Max Planck Institute for Molecular Genetics, Berlin, Germany, September 14

» More

October 04, 2009

American Conference on Pharmacometrics (ACoP), Mystic, CT, USA, October 4-7

» More